Delivery of Care
Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
Doctors at the Tata Memorial Hospital in Mumbai have shown that an ultra-low dose of the immunotherapy drug nivolumab significantly improves survival in patients with recurrent or newly diagnosed head and neck cancers. The findings of the single-centre phase III…
What do you say when your patient can’t stop worrying about recurrence? Here’s what you told us
It isn’t over when treatment’s over. Even if, as far as the clinician is concerned, therapy has been successful and the cancer is effectively ‘cured’, cancer patients often experience a nagging – sometimes devastating – fear that their cancer will…
HPV vaccination set to be rolled out across Turkey… with controversial exclusions
Turkey’s minister of health announced on 24th November that the government is planning to start an HPV vaccine rollout. “We will start vaccination with a designated group and gradually expand its scope,” said health minister Fahrettin Koca in a speech at…
Helping cancer patients preserve their fertility in one of Europe’s least supportive states
It was the end of the first pandemic summer, when Edyta, a 35-year-old active entrepreneur from Łódź, Poland, received an email informing her that she had been diagnosed with breast cancer metastasised to the lymph nodes. Naturally, her first thoughts…
Tackling cancer when there’s no functioning state: the Al-Amal model
Six years ago, Mada accompanied her daughter to the gynaecologist for an early pregnancy scan. Whilst she was there, the physician suggested Mada herself get a check-up. “The doctor at first thought I had a very large cyst on my…
Unicorns for Ukraine: mobilising to meet patients’ changing cancer care needs
When Russia invaded Ukraine on February 24, consultant clinical oncologist Mohammed Hojouj put out a call for help: “Cancers do not stop growing because there is a war. But cancer patients stop being seen as a priority.” The story he…
India’s Lung Connect shows value of online cancer support in low-income settings
It was April 2020. Just a few weeks earlier, India had imposed a national lockdown – among the harshest in the world. Ramkrishna Bhadhury, 44, a farmer from a small village in Nalikul, West Bengal, was feeling increasingly dejected and…
Surviving childhood cancer in Africa: helping families stick with the treatment plan is key
Faced with poverty, low maternal education and fears about treatment effects, many families in sub-Saharan Africa are abandoning cancer treatment for children and young people, harming chances of survival. In Kenya and Zambia, for instance, treatments for childhood cancers are…
Precision care: supporting our patients starts with asking them what they want and need
Two weeks after receiving a brain tumour diagnosis, Martin was copied into an email from one of his healthcare team telling his GP that Martin was “understandably devastated by his diagnosis”. The words came as a shock. “My healthcare team…
Chemobrain: it’s real, it’s troublesome and it deserves more attention
Fiona Henderson was part way through her psychology degree when she received her breast cancer diagnosis. Right after treatments finished, she returned to her studies – initially without a problem. “Three or four months later, I really struggled. I was…